Japan’s first Mpox death sheds light on immunocompromised vulnerability
In a sobering turn of events, Japan has reported its first death from mpox, a viral disease that has been causing concern since its first [more…]
In a sobering turn of events, Japan has reported its first death from mpox, a viral disease that has been causing concern since its first [more…]
In a monumental stride forward in medical science, the U.S. Food and Drug Administration (FDA) has granted approval for the first gene-editing treatment for sickle [more…]
In a concerning turn of events, South Korea is grappling with a resurgence of highly pathogenic avian influenza (AI) as health authorities confirmed a second [more…]
In the heart of Rio de Janeiro, where the rhythms of samba once danced in harmony with a groundbreaking movement to provide affordable HIV treatment, [more…]
Japan, known for its rich history and advanced technology, is facing a daunting challenge as its population continues to gray and decline. Government data has [more…]
In a groundbreaking development, the Food and Drug Administration (FDA) has granted approval to Eli Lilly’s blockbuster drug, tirzepatide, for the treatment of obesity in [more…]
Novo Nordisk, a global pharmaceutical company known for its innovative treatments in diabetes care and obesity management, recently announced an encouraging development regarding the accessibility [more…]
In a growing health crisis, a multistate salmonella outbreak has swept across 22 U.S. states, resulting in at least 73 reported cases and 15 hospitalizations, [more…]
In a significant development, GlaxoSmithKline (GSK) announced promising results from a late-stage clinical trial for their vaccine, Arexvy, which exhibits the potential to protect adults [more…]
In a recent announcement, the French National Medicines Safety Agency (ANSM) has raised concerns about the use of oral vasoconstrictor medications commonly used to relieve [more…]